Related Experiment Video

Updated: Jun 2, 2026

Long-Term Mouse Spinal Cord Organotypic Slice Culture as a Platform for Validating Cell Transplantation in Spinal Cord Injury
07:37

Long-Term Mouse Spinal Cord Organotypic Slice Culture as a Platform for Validating Cell Transplantation in Spinal Cord Injury

Published on: April 12, 2024

Target populations for first-in-human embryonic stem cell research in spinal cord injury

Frédéric Bretzner1, Frédéric Gilbert, Françoise Baylis

  • 1Department of Anatomy and Neurobiology, Dalhousie University, Halifax, Nova Scotia B3H 3J5, Canada. frederic.bretzner@dal.ca

Cell Stem Cell
|May 10, 2011
PubMed

Insights

Geron

Area of Science:

  • Regenerative medicine
  • Stem cell therapy
  • Neurology

Background:

  • Geron initiated the first human clinical trial using human embryonic stem cells (hESCs).
  • This trial focuses on hESC-derived therapies with potential applications in spinal cord injury (SCI).

Purpose of the Study:

  • To address safety and efficacy concerns of hESC-based therapies in SCI.
  • To discuss ethical considerations for subject selection in clinical trials.
  • To propose alternative patient populations for future hESC research.

Main Methods:

  • Review of current research and ethical considerations for hESC therapies.
  • Analysis of potential benefits and risks for different patient groups.
  • Proposal of stratified trial designs for SCI and multiple sclerosis (MS).

Main Results:

  • The study highlights critical questions surrounding the safety and efficacy of hESC-derived treatments.
  • Ethical considerations regarding fair subject selection are paramount.
  • Specific SCI and MS patient subgroups may be better suited for initial trials.

Conclusions:

  • Further investigation into safety and efficacy is required before widespread application of hESC therapies.
  • Careful consideration of patient selection is essential for ethical and effective clinical trials.
  • Alternative patient populations, including chronic complete SCI, subacute incomplete SCI, and primary progressive MS, warrant further research for hESC-based treatments.

More Related Videos

Neural Stem Cell Transplantation in Experimental Contusive Model of Spinal Cord Injury10:56

Neural Stem Cell Transplantation in Experimental Contusive Model of Spinal Cord Injury

Published on: December 17, 2014

Promotion of Survival and Differentiation of Neural Stem Cells with Fibrin and Growth Factor Cocktails after Severe Spinal Cord Injury09:56

Promotion of Survival and Differentiation of Neural Stem Cells with Fibrin and Growth Factor Cocktails after Severe Spinal Cord Injury

Published on: July 27, 2014

Related Concept Videos

Embryonic Stem Cells00:57

Embryonic Stem Cells

Embryonic stem (ES) cells were first discovered in mice in 1981 by Martin Evans. In 1998, James Thomson identified a method to isolate embryonic stem cells from humans. Human embryonic stem cells (hESCs) are obtained from 3-5 day old embryos that remain unused after an in vitro fertilization procedure.
ES cells are grown in a culture medium where they can divide indefinitely, creating ES cell lines. Under certain conditions, ES cells can differentiate, either spontaneously into a variety of...
Embryonic Stem Cells00:58

Embryonic Stem Cells

Embryonic stem (ES) cells are undifferentiated pluripotent cells, meaning they can produce any cell type in the body. This gives them tremendous potential in science and medicine since they can generate specific cell types for use in research or to replace body cells lost due to damage or disease.
Induced Pluripotent Stem Cells01:13

Induced Pluripotent Stem Cells

Stem cells are undifferentiated cells that divide and produce different types of cells. Ordinarily, cells that have differentiated into a specific cell type are post-mitotic—that is, they no longer divide. However, scientists have found a way to reprogram these mature cells so that they “de-differentiate” and return to an unspecialized, proliferative state. These cells are also pluripotent like embryonic stem cells—able to produce all cell types—and are therefore called induced pluripotent stem...
Induced Pluripotent Stem Cells01:06

Induced Pluripotent Stem Cells

Stem cells are undifferentiated cells that divide and produce different cell types. Ordinarily, cells that have differentiated into a specific cell type are terminally differentiated; however, scientists have found a way to reprogram these mature cells so that they dedifferentiate and return to an unspecialized, proliferative state. These cells are pluripotent like embryonic stem cells—able to produce all cell types—and are called induced pluripotent stem cells (iPSCs).
Somatic cells are...
Stem Cell Culture01:17

Stem Cell Culture

Stem cell research aims to find ways to use stem cells to regenerate and repair cellular damage. Over time, most adult cells undergo the wear and tear of aging and lose their ability to divide and repair themselves. Stem cells do not display a particular morphology or function. Adult stem cells, which exist as a small subset of cells in most tissues, keep dividing and can differentiate into a number of specialized cells generally formed by that tissue. These cells enable the body to renew and...
Stem Cell Therapy for Tissue Regeneration01:21

Stem Cell Therapy for Tissue Regeneration

Stem cell therapy is a method used in regenerative medicine to repair and restore function to damaged tissues and organs. Stem cells have the potential to proliferate and differentiate into various tissue types, making them ideal candidates for tissue regeneration. For example, hematopoietic stem cell transplants are commonly used in blood cancer treatment to replenish damaged bone marrow and restore healthy blood cells.
Types of Stem Cells used in Stem Cell Therapy
The two main cell types that...